PrEP-001 + G-004
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedAbout PrEP-001 + G-004
PrEP-001 + G-004 is a phase 2 stage product being developed by hVIVO for Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT03296917. Target conditions include Asthma.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03296917 | Phase 2 | Completed |
Competing Products
20 competing products in Asthma